InMed Pharmaceuticals (MWG) Revenue

1 Followers

InMed Pharmaceuticals Revenue

InMed Pharmaceuticals had a revenue of 2.06B in the quarter ending Jun 30, 2026, with Infinity%. This bring the company's revenue in the last twelve months to 2.06B, Decreased 51110.74%. In the fiscal year ending Jun 30, 2026, InMed Pharmaceuticals had annual revenue of 3.18B with 64167.28% growth.

Revenue (ttm)

2.06B

Revenue Growth

-63.39%

P/S Ratio

<0.01

Revenue/Employee

€529,416,000

Employees

Market Cap

€6.71M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Jun 30, 2026	3.18B	3.17B	+64,167.28%
Jun 30, 2025	4.94M	344.90K	+7.50%
Jun 30, 2024	4.60M	462.17K	+11.18%
Jun 30, 2023	4.14M	3.05M	+279.61%
Jun 30, 2022	1.09M	―	+∞%
Jun 30, 2021	―	―	―
Jun 30, 2020	―	―	―
Jun 30, 2019	―	―	―
Jun 30, 2018	―	―	―
Jun 30, 2017	―	―	―